Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Mi | HCW Biologics Sinks on Alliance with WY Biotech | - | Baystreet.ca | ||
Mi | HCW Biologics geht Partnerschaft mit WY Biotech für Immuntherapie ein | 1 | Investing.com Deutsch | ||
Mi | HCW Biologics Inc.: HCW Biologics Completes Deliverable and Solidifies License Agreement with WY Biotech | 3 | GlobeNewswire (USA) | ||
30.05. | HCW Biologics Inc. - 8-K, Current Report | 1 | SEC Filings | ||
23.05. | HCW Biologics Inc. - 8-K, Current Report | 1 | SEC Filings | ||
16.05. | HCW Biologics GAAP EPS of -$0.05, revenue of $5.1K | 1 | Seeking Alpha | ||
HCW BIOLOGICS Aktie jetzt für 0€ handeln | |||||
16.05. | HCW Biologics GAAP EPS of -$0.20, revenue of $1.1M | 3 | Seeking Alpha | ||
16.05. | HCW Biologics clings on with $5M lifeline to fund phase 1 alopecia trial | 1 | FierceBiotech | ||
16.05. | HCW Biologics Inc.: HCW Biologics Reports First Quarter 2025 Business Highlights and Financial Results | 101 | GlobeNewswire (Europe) | MIRAMAR, Fla., May 15, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the "Company" or "HCW Biologics") (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing... ► Artikel lesen | |
15.05. | HCW Biologics Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
15.05. | HCW Biologics Inc. - 8-K, Current Report | 2 | SEC Filings | ||
14.05. | HCW Biologics jumps 16% on pricing $5M follow on offering | 1 | Seeking Alpha | ||
14.05. | HCW Biologics Inc.: HCW Biologics Announces Pricing of $5.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules | 1 | GlobeNewswire (USA) | ||
13.05. | HCW Biologics Inc. - S-1/A, General form for registration of securities | 1 | SEC Filings | ||
13.05. | HCW Biologics präsentiert neuartigen CAR-T-Zell-Verstärker | 5 | Investing.com Deutsch | ||
13.05. | HCW Biologics presents novel CAR-T cell enhancer | 2 | Investing.com | ||
13.05. | HCW Biologics Inc.: HCW Biologics Announces Positive Results of Studies of Proprietary Compound, HCW9206 and Availability for Commercialization | 111 | GlobeNewswire (Europe) | Addresses key challenges for CAR-T therapies Potential to significantly reduce costs and improve clinical efficacy of engineered effector T cells Data Shared at 2025 Annual Meeting of American Association... ► Artikel lesen | |
09.05. | HCW Biologics Inc. - S-1, General form for registration of securities | - | SEC Filings | ||
22.04. | HCW Biologics Inc. - 8-K, Current Report | 3 | SEC Filings | ||
14.04. | HCW Biologics Inc. - 8-K, Current Report | 3 | SEC Filings |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
PALATIN TECHNOLOGIES | 0,079 | 0,00 % | Palatin Technologies Q1 Net Loss Narrows On Lower Expenses | WASHINGTON (dpa-AFX) - Palatin Technologies, Inc. (PTNT.PK), a biopharmaceutical company, on Wednesday reported narrower net loss in its first quarter with sharply lower operating expenses.Palatin... ► Artikel lesen | |
BIOXXMED | 0,410 | -0,49 % | XETR DELETION OF INSTRUMENTS FROM XETRA - 31.03.2025 | The following instruments on Xetra do have their last trading day on 31.03.2025.Die folgenden Instrumente auf Xetra haben ihren letzten Handelstag am 31.03.2025.ISIN NameDE000A4BGGE4 bioXXmed AG ► Artikel lesen | |
VIVOSIM LABS | 1,570 | -100,00 % | VivoSim Labs, INC. - 10-K, Annual Report | ||
OCUGEN | 0,839 | +0,62 % | Ocugen, Inc. Announces Signing of Binding Term Sheet for the License of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea | Upfront fees and near-term development milestone payments totaling up to $11 millionSales milestones of $150 million or more in first 10 years of commercializationRoyalties equaling 25% of net salesOcugen... ► Artikel lesen | |
SIRONA BIOCHEM | 0,037 | -100,00 % | Sirona Biochem gibt Finanzierung mittels Wandelschuldverschreibung bekannt | Vancouver, British Columbia, 22. April 2025 / IRW-Press / Sirona Biochem Corp. (TSX-V: SBM) (FWB: ZSB) (OTC: SRBCF) ("Sirona" oder das "Unternehmen") gibt eine nicht vermittelte Privatplatzierung... ► Artikel lesen | |
BIO-GATE | 1,050 | -1,87 % | Bio-Gate platziert Wandelanleihen im Gesamtwert von 550.000 Euro | Bio-Gate meldet die Platzierung zweier Wandelschuldverschreibungen mit einem Gesamtvolumen von 550.000 Euro. Eine Tranche über 300.000 Euro stammt aus einer am 3. Juni beschlossenen Emission im Gesamtnennbetrag... ► Artikel lesen | |
DEFENCE THERAPEUTICS | 0,514 | +3,63 % | Defence Therapeutics Inc.: Defence Therapeutics Opens U.S. Laboratory in Boston-Cambridge Biotech Hub | Montreal, Quebec--(Newsfile Corp. - June 2, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a leading biotechnology company specializing in advanced... ► Artikel lesen | |
VAXART | 0,358 | +3,89 % | Vaxart, Inc.: Vaxart Announces Adjournment of Annual Meeting of Stockholders | ||
BURCON NUTRASCIENCE | 0,070 | -3,84 % | Burcon NutraScience Corporation: Burcon to Participate in 2025 Canadian Climate Investor Conference | Vancouver, British Columbia--(Newsfile Corp. - May 28, 2025) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in the development of... ► Artikel lesen | |
CELLECTAR BIOSCIENCES | 0,346 | -1,70 % | Cellectar +147%: Ich nehme die Gewinne mit! | Meine Spekulation geht auf: Cellectar Biosciences (WKN: A3DQSD) knallt heute in der Spitze um bis zu +147% durch die Decke, nachdem ich im März ein großes Comeback der Aktie in Aussicht gestellt hatte.... ► Artikel lesen | |
AFFIMED | 0,972 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 28.05.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 28.05.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 28.05.2025ISIN NameBMG3728V1090 GAN... ► Artikel lesen | |
AIM IMMUNOTECH | 0,073 | -100,00 % | AIM ImmunoTech Inc.: AIM ImmunoTech Announces Trading Under the Ticker AIMI on the Pink Open Market | OCALA, Fla., April 07, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. ("AIM" or the "Company") (OTC Pink: AIMI) - an immuno-pharma company focused on the research and development of therapeutics to... ► Artikel lesen | |
IMMUNIC | 0,678 | +1,35 % | Immunic sammelt 65 Millionen Dollar ein - Aktie reagiert | Immunic meldet für die erste Tranche einer Kapitalmaßnahme einen Bruttoerlös von rund 65 Millionen Dollar. Das Biotech-Unternehmen platzierte im Rahmen eines öffentlichen Angebots vorfinanzierte Aktien-Warrants... ► Artikel lesen | |
T2 BIOSYSTEMS | 0,105 | -0,47 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 20.02.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 20.02.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 20.02.2025.ISIN NameCA24703H1029 DELIVRA... ► Artikel lesen | |
CEL-SCI | 2,360 | 0,00 % | Pre-market Movers: Navitas Semiconductor, Longevity Health, CEL-SCI, Hyperscale Data, Sunrun | PHILADELPHIA (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 06.35 A.M. ET).In the Green Navitas Semiconductor Corporation (NVTS) is... ► Artikel lesen |